 gp100 Melanoma Antigen
"gp100 Melanoma Antigen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A melanosome-associated protein that plays a role in the maturation of the MELANOSOME.
| Descriptor ID |
D058951
|
| MeSH Number(s) |
D12.776.543.306 D12.776.624.301.500 D23.050.285.439.500
|
| Concept/Terms |
gp100 Melanoma Antigen- gp100 Melanoma Antigen
- Antigen, gp100 Melanoma
- Melanoma Antigen, gp100
- gp100 Melanoma-Associated Antigen
- Antigen, gp100 Melanoma-Associated
- Melanoma-Associated Antigen, gp100
- gp100 Melanoma Associated Antigen
- ME20 Antigen
- Melanocyte Lineage-Specific Antigen gp100
- Melanocyte Lineage Specific Antigen gp100
- Melanocyte Protein Pmel 17
- Silver Locus Protein Homolog
- Melanoma-Associated Antigen gp100
- Melanoma Associated Antigen gp100
- Melanoma-Associated ME20 Antigen
- Antigen, Melanoma-Associated ME20
- ME20 Antigen, Melanoma-Associated
- Melanoma Associated ME20 Antigen
- MLSA gp100
- Pmel17 Melanoma Antigen
- Melanoma Antigen, Pmel17
- gp100 Melanocyte Differentiation Antigen
- Melanoma Antigen Glycoprotein 100
|
Below are MeSH descriptors whose meaning is more general than "gp100 Melanoma Antigen".
Below are MeSH descriptors whose meaning is more specific than "gp100 Melanoma Antigen".
This graph shows the total number of publications written about "gp100 Melanoma Antigen" by people in this website by year, and whether "gp100 Melanoma Antigen" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 | | 2011 | 0 | 1 | 1 | | 2013 | 1 | 1 | 2 | | 2014 | 0 | 2 | 2 | | 2016 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "gp100 Melanoma Antigen" by people in Profiles.
-
Slaney CY, von Scheidt B, Davenport AJ, Beavis PA, Westwood JA, Mardiana S, Tscharke DC, Ellis S, Prince HM, Trapani JA, Johnstone RW, Smyth MJ, Teng MW, Ali A, Yu Z, Rosenberg SA, Restifo NP, Neeson P, Darcy PK, Kershaw MH. Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting. Clin Cancer Res. 2017 May 15; 23(10):2478-2490.
-
Klarquist J, Eby JM, Henning SW, Li M, Wainwright DA, Westerhof W, Luiten RM, Nishimura MI, Le Poole IC. Functional cloning of a gp100-reactive T-cell receptor from vitiligo patient skin. Pigment Cell Melanoma Res. 2016 May; 29(3):379-84.
-
Chandran SS, Paria BC, Srivastava AK, Rothermel LD, Stephens DJ, Dudley ME, Somerville R, Wunderlich JR, Sherry RM, Yang JC, Rosenberg SA, Kammula US. Persistence of CTL clones targeting melanocyte differentiation antigens was insufficient to mediate significant melanoma regression in humans. Clin Cancer Res. 2015 Feb 01; 21(3):534-43.
-
Bartlett EK, Fetsch PA, Filie AC, Abati A, Steinberg SM, Wunderlich JR, White DE, Stephens DJ, Marincola FM, Rosenberg SA, Kammula US. Human melanoma metastases demonstrate nonstochastic site-specific antigen heterogeneity that correlates with T-cell infiltration. Clin Cancer Res. 2014 May 15; 20(10):2607-2616.
-
Liu B, Zhong S, Malecek K, Johnson LA, Rosenberg SA, Zhu C, Krogsgaard M. 2D TCR-pMHC-CD8 kinetics determines T-cell responses in a self-antigen-specific TCR system. Eur J Immunol. 2014 Jan; 44(1):239-50.
-
Chen S, Li Y, Depontieu FR, McMiller TL, English AM, Shabanowitz J, Kos F, Sidney J, Sette A, Rosenberg SA, Hunt DF, Mariuzza RA, Topalian SL. Structure-based design of altered MHC class II-restricted peptide ligands with heterogeneous immunogenicity. J Immunol. 2013 Nov 15; 191(10):5097-106.
-
Mosenson JA, Zloza A, Klarquist J, Barfuss AJ, Guevara-Patino JA, Poole IC. HSP70i is a critical component of the immune response leading to vitiligo. Pigment Cell Melanoma Res. 2012 Jan; 25(1):88-98.
-
Klarquist J, Barfuss A, Kandala S, Reust MJ, Braun RK, Hu J, Dilling DF, McKee MD, Boissy RE, Love RB, Nishimura MI, Le Poole IC. Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cells. Am J Pathol. 2009 Dec; 175(6):2463-72.
-
Hutton SM, Spritz RA. Comprehensive analysis of oculocutaneous albinism among non-Hispanic caucasians shows that OCA1 is the most prevalent OCA type. J Invest Dermatol. 2008 Oct; 128(10):2442-50.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|